Sunday, October 31, 2004
Friday, October 29, 2004
What to put on your hot dog
Pardon me, do you have any Grey Poupon?(I actually prefer French's to Grey Poupon myself, but what I really like is spicy yellow mustard.)
Wednesday, October 27, 2004
A very Kerry column
If elected, Kerry would probably be a mediocre, unloved president on the order of Jimmy Carter. And I won't have a second's regret about voting for him. Kerry's failings are minuscule when weighed against the massive damage to America's standing in the world, our economic future, and our civic institutions that would likely result from a second Bush term.
Tuesday, October 26, 2004
Thursday, October 21, 2004
Monday, October 18, 2004
And still more about drugs...
The little secret in the classical music world - dirty or not - is that the drugs have become nearly ubiquitous. So ubiquitous, in fact, that their use is starting to become a source of worry. Are the drugs a godsend or a crutch?
The article also notes that experts still don't agree that the drug should be removed from the market. The safety of similar Cox-2 drugs is still in question.
Gilmartin was clear that the trial should be halted and that the drug might have to be taken off the market . "Look Peter, we're going to make this decision based on what's in the best interest of science and patient safety," Gilmartin recalled saying. "It's not that we're unaware of the consequences, but it's a deep-seated belief that if you do the right thing, rewards will follow," he said of the decision to pull the drug.
The decision was also sound litigation strategy. The company was already facing two class action lawsuits alleging patient harm from Vioxx. Anything that smacked of a cover-up would have strengthened the plaintiffs' hands.
"Running away from your problems, denial, is the worst possible choice," said Anthony M. Sabino, professor of business law at St. John's University.
Thursday, October 14, 2004
The needle and the damage done
Note that even if the prices are high enough to earn the company a modest profit the point is that they are not high enough to make it worthwhile to make a surplus of vaccine that can be sold in the event of a contamination problem, as has happened this year. If the firms can't price high during a shortage then there is no incentive to plan for a shortage. Even without legal price caps there are significant disincentives to high prices. Here is a CDC spokesperson (link to audio file) on recent price increases:
Is it any wonder that firms don't want in on this market?
Shame on the people who are price gouging. This is a reprehensible thing to be doing. I think an immoral thing.
Friday, October 08, 2004
Mistakes were made
There were plenty of people around during the installation who could and should have seen the missing and misplaced letters, she said.On the bright side, she was somehow able to spell "Tonantzin (the Aztec goddess of motherhood), Tutankhamen (an Egyptian pharaoh) and Archipenko (an American sculptor)
"Even though I was on my hands and knees laying the installation out, I didn't see it," she said.
Anyway, she said, the mistakes wouldn't even register with a true artisan.